Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey
Authors:
- Eva W H KorteEKEva W H Korte
- Marjolein A J HielMHMarjolein A J Hiel
- Maria C BollingMBMaria C Bolling
- Patrick DunnPDPatrick Dunn
- Dédée F MurrellDédée F Murrell
- Victoria P WerthVWVictoria P Werth
- Marc YaleMYMarc Yale
- Phyllis I SpulsPSPhyllis I Spuls
- Joost M MeijerJMJoost M Meijer
- Barbara HorváthBHBarbara Horváth
Open Access
- 13 September 2025
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (1) , 165-167
Abstract
This study analysed 32 failed drug development trials and surveyed 56 experts in the field of autoimmune bullous diseases to identify key challenges in bullous pemphigoid and pemphigus research. Clinical trials primarily failed due to unmet efficacy endpoints and recruitment difficulties, with experts highlighting the need to improve endpoint selection and patient enrolment strategies through international collaboration to develop more effective trial designs and advance new therapeutic options.Keywords
This publication has 6 references indexed in Scilit:
- Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized StudyJournal of Investigative Dermatology, 2024
- The Importance of Patient-Focused Drug Development in Pemphigus and PemphigoidJournal of Investigative Dermatology, 2023
- Home-Based Interventions may Increase Recruitment, Adherence, and Measurement of outcomes in Clinical Trials of Stroke RehabilitationJournal of Stroke and Cerebrovascular Diseases, 2021
- Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trialThe Lancet Neurology, 2021
- Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of expertsJournal of the American Academy of Dermatology, 2012
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusJournal of the American Academy of Dermatology, 2008